Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia.
AUTOR(ES)
Davey, R T
RESUMO
In summary, recent advances in our ability to diagnose, treat, and prevent recurrences of pneumocystis pneumonia have significantly improved the clinical management of this infection, especially in HIV-1-infected individuals. As current investigations allow our therapeutic armamentarium in this disease to be strengthened even further, it is likely that pneumocystis pneumonia will pose a diminishing threat to those patients currently most susceptible to this infection.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=171632Documentos Relacionados
- Routine diagnosis of Pneumocystis carinii pneumonia.
- Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia.
- Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
- Pneumocystis carinii pneumonia.
- Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia.
